Ivertac 12 Tablet contains Ivermectin 12 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively and with high affinity to glutamate-gated chloride ion channels in the nerve and muscle cells of invertebrates, leading to increased permeability to chloride ions, hyperpolarization, and paralysis of the parasite. It is effective against a range of parasitic infestations including strongyloidiasis, onchocerciasis, and other nematode infections. Ivertac 12 is typically administered orally, with dosage and duration determined by the type and severity of infection. It is generally well tolerated, but may cause side effects such as dizziness, nausea, diarrhea, or mild skin rash. Caution is advised in patients with impaired liver function or those taking concomitant medications that may interact with Ivermectin. It is contraindicated in individuals with known hypersensitivity to Ivermectin or any of the tablet excipients. Ivertac 12 should be used under medical supervision, with adherence to prescribed dosage to ensure efficacy and minimize the risk of resistance development. Pregnant or breastfeeding women should consult a healthcare professional before use. This medication is an essential component in the management of parasitic diseases, contributing significantly to improved patient outcomes.